-
21.
公开(公告)号:AU783707B2
公开(公告)日:2005-11-24
申请号:AU5421600
申请日:2000-06-23
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROGER BURKHARD , SCHRODER HARTWIG , ZELDER OSKAR , HABERHAUER GREGOR
-
公开(公告)号:AU2003298216A1
公开(公告)日:2004-07-14
申请号:AU2003298216
申请日:2003-12-19
Applicant: BASF AG
Inventor: SCHRODER HARTWIG , HAEFNER STEFAN , LIEBL WOLFGANG , KLOPPROGGE CORINNA , ZELDER OSKAR , KROGER BURKHARD
IPC: C12P13/04
Abstract: The invention relates to a method for producing an amino acid comprising culturing a microorganism of the genus Corynebacterium or Brevibacterium wherein said microorganism is partially or completely deficient in at least one of the gene loci of the the group which is formed by otsAB, treZ and treS, and subsequent isolation of the amino acid from the culture medium.
-
公开(公告)号:AU2003242537A1
公开(公告)日:2003-12-02
申请号:AU2003242537
申请日:2003-05-13
Applicant: BASF AG
Inventor: KLOPPROGGE CORINNA , ZELDER OSKAR , KROGER BURKHARD , SCHRODER HARTWIG , HAFNER STEFAN , LEE HEUNG-SHICK
Abstract: Isolated polypeptide sequence having the sequence of SEQ ID NO:1 or muteins thereof having the ability to bind cAMP and repress the expression of the aceB gene of C. glutamicum and which can be obtained from SEQ ID NO:1 by inserting, deleting or substituting up to 20% of the amino acids.
-
24.
公开(公告)号:AU2002363458A1
公开(公告)日:2003-05-19
申请号:AU2002363458
申请日:2002-10-31
Applicant: BASF AG
Inventor: KROGER BURKHARD , HABERHAUER GREGOR , POMPEJUS MARKUS , KLOPPROGGE CORINNA , SCHRODER HARTWIG , ZELDER OSKAR
Abstract: The invention relates to novel nucleic acid molecules, to their use for constructing genetically improved microorganisms and to methods for producing fine chemicals, in particular, amino acids by using these genetically modified microorganisms.
-
公开(公告)号:AU2002349017A1
公开(公告)日:2003-05-19
申请号:AU2002349017
申请日:2002-10-31
Applicant: BASF AG
Inventor: POMPEJUS MARKUS , KROGER BURKHARD , KLOPPROGGE CORINNA , ZELDER OSKAR , SCHRODER HARTWIG , HABERHAUER GREGOR
Abstract: The invention relates to novel nucleic acid molecules, to the use thereof in the construction of genetically improved microorganisms and to a method for producing fine chemical products, in particular amino acids, by means of said genetically improved microorganisms.
-
公开(公告)号:AU2002346805A1
公开(公告)日:2003-05-19
申请号:AU2002346805
申请日:2002-10-31
Applicant: BASF AG
Inventor: SCHRODER HARTWIG , KLOPPROGGE CORINNA , KROGER BURKHARD , ZELDER OSKAR , HABERHAUER GREGOR , POMPEJUS MARKUS
IPC: C07H21/04 , C07K14/34 , C12N1/21 , C12N9/12 , C12N9/16 , C12N9/90 , C12N15/31 , C12P13/08 , C12R1/15
Abstract: The invention relates to novel nucleic acid molecules, to the use thereof for constructing genetically improved microorganisms and to methods for preparing fine chemicals, in particular amino acids, with the aid of said genetically improved microorganisms.
-
公开(公告)号:AU2002339420A1
公开(公告)日:2003-02-24
申请号:AU2002339420
申请日:2002-07-10
Applicant: BASF AG
Inventor: DOVAL JOSE L REVUELTA , KROGER BURKHARD , KAROS MARVIN , ALTHOFER HENNING
IPC: C07K14/37 , C07K14/47 , C12N1/15 , C12N15/30 , C12P25/00 , C12Q1/68 , C07K16/14 , C12N15/80 , C12N15/52 , C12Q1/02
Abstract: The present invention relates to novel polynucleotides from Ashbya gossypii; to oligonucleotides hybridizing therewith; to expression cassettes and vectors which comprise these polynucleotides; to microorganisms transformed therewith; to polypeptides encoded by these polynucleotides; and to the use of the novel polypeptides and polynucleotides as targets for improving stress resistance and, in particular, improving vitamin B2 production in microorganisms of the genus Ashbya.
-
公开(公告)号:ES2162916T3
公开(公告)日:2002-01-16
申请号:ES95914301
申请日:1995-03-23
Applicant: BASF AG
Inventor: BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROGER BURKHARD
IPC: C07D251/26 , A61K31/00 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
公开(公告)号:SK17892000A3
公开(公告)日:2001-09-11
申请号:SK17892000
申请日:1999-06-04
Applicant: BASF AG
Inventor: KOCK MICHAEL , HOGER THOMAS , KROGER BURKHARD , OTTERBACH BERND , LUBISCH WILFRIED , LEMAIRE HANS-GEORG
IPC: A01K67/027 , A61K38/00 , A61K38/45 , A61K48/00 , A61K49/00 , A61P43/00 , C07K14/455 , C12N1/15 , C12N1/19 , C12N5/10 , C12N9/10 , C12N15/09 , C12N15/54 , C12Q1/68 , G01N33/53 , C12N15/10 , A61K31/70
Abstract: The invention relates to poly(ADP-ribose)polymerase (PARP) homologs which have an amino acid sequence which has a) a functional NAD+ binding domain and b) no zinc finger sequence motif of the general formula CX2CXmHX2C in which m is an integral value from 28 or 30, and the X radicals are, independently of one another, any amino acid; and the functional equivalents thereof; nucleic acids coding therefor; antibodies with specificity for the novel protein; pharmaceutical and gene therapy compositions which comprise products according to the invention; methods for the analytical determination of the proteins and nucleic acids according to the invention; methods for identifying effectors or binding partners of the proteins according to the invention; novel PARP effectors; and methods for determining the activity of such effectors.
-
公开(公告)号:AU695193B2
公开(公告)日:1998-08-06
申请号:AU2135695
申请日:1995-03-23
Applicant: BASF AG
Inventor: BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROGER BURKHARD , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED
IPC: C07D251/26 , A61K31/00 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
-
-
-
-
-
-
-
-